Search Results 801-810 of 15850 for Linaclotide
Research · Analyzing the genetic makeup of breast cancer cells to understand how DNA changes affect response to cancer treatments and personalize treatment ...
This randomized Phase III, multicenter, open-label study is designed to evaluate the safety and efficacy of atezolizumab in combination with carboplatin + nab- ...
Share · Tweet. See also. Abdominal aortic aneurysm · Acne · Actinic keratosis · Atrial septal defect (ASD) · Autoimmune pancreatitis · Back pain ...
About this study. The purpose of this study is to examine the capability of contrast enhanced breast PCD-CT in staging breast cancer within the breasts and ...
The study will include a Phase 1 part to determine the recommended dose of JCARH125 in subjects with relapsed and/or refractory multiple myeloma, followed by a ...
This is a prospective, multicenter, randomized, double-blinded, placebo-controlled Phase 3 study of a microbiota suspension of intestinal microbes. Patients who ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
Finding new ways to use bone marrow transplant, including pediatric hemoglobinopathies and inherited metabolic diseases; Improving quality of life for bone ...
The primary purpose of this study is to determine if bortezomib, daratumumab, lenalidomide and dexamethasone (Btz-DRd) consolidation followed by daratumumab ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.